Hamostaseologie

Papers
(The median citation count of Hamostaseologie is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation156
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism62
Simply Online? Lessons from Virtual Scientific Conferences for the Post-COVID-19 Era54
COVID-19: Cardio-pulmonary and Vascular Manifestations29
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report26
Inherited Platelet Disorders: A Short Introduction22
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)18
Treatment of Atypical Clots14
Theme Issue: “Critical Management Decisions in Hemostasis and Thrombosis”14
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism13
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz13
GTH News13
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria13
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation12
11
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig11
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko10
Haemostaseological pearls10
10
Hemostaseology in Pediatrics10
GTH News9
9
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?9
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)9
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction9
Thromboinflammation as a Driver of Venous Thromboembolism9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies8
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management7
A Review of FXIa Inhibition as a Novel Target for Anticoagulation7
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis7
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect7
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms7
Cerebral Venous Thrombosis: What's New?7
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice6
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism6
Emicizumab for All Pediatric Patients with Severe Hemophilia A6
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien6
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia6
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei6
Management of Disseminated Intravascular Coagulation in Acute Leukemias6
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms5
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics5
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life5
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause5
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)5
5
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten4
Anti-inflammatory Strategies in Atherosclerosis4
Interventional Treatment Options in Children with Extracranial Vascular Malformations4
Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period4
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert4
Efgartigimod hilft bei Immunthrombozytopenie4
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung4
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations4
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms3
VTE Risk Assessment and Prevention in Pregnancy3
Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review3
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH3
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy3
Diagnosing Inherited Platelet Disorders: Modalities and Consequences3
3
Cardiovascular Risk Assessment in COVID-193
Bleeding Risk Assessment in Patients with Venous Thromboembolism3
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia3
Pulmonary Hypertension and COVID-193
Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical Research3
Nachtrag zur kritischen Diskussion über das Deutsche Hämophilieregister (DHR) anlässlich der GTH-Jahrestagung in Frankfurt 2023, aktuelle Informationen zur Gefährdung der Versorgung mit Blutplasmaprod3
Does a Simple Blood Gas Analysis and the Clinical Impression Predict Trauma-Induced Coagulopathy?3
Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study3
GTH News3
A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy3
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience3
Editorial3
Update on Cancer-Associated Venous Thromboembolism in Children3
GTH News3
Markers of Hereditary Thrombophilia with Unclear Significance3
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far3
Evaluation der Vertriebswegänderung und der gesetzlichen Folgeänderungen für Gerinnungsfaktorenzubereitungen; Digitalisierung im Gesundheitswesen: Elektronische Patientenakte; Aktueller Stand bzgl. ne3
Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?3
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia3
Platelets in Myocardial Ischemia/Reperfusion Injury2
New Anticoagulants in Neonates, Children, and Adolescents2
Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung2
Treatment of Cancer-Associated Thrombosis: An Update2
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?2
New Opportunities for Diagnosis and Prognosis of Stroke: The Benefits of Across Border Approaches2
An Update on Laboratory Diagnostics in Haemophilia A and B2
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology2
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline2
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline2
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert2
Venous Thromboembolism Issues in Women2
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India2
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions2
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline2
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment2
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces2
Pulmonary Embolism: Don't Start Me to Talkin'1
Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report1
Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation1
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren1
COVID-19: Kinetikmessung der thrombozytären ATP-Freisetzung prognostisch hilfreich1
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia1
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert1
Blutungsneigung bei Morbus Waldenström: Mögliche Ursachen und Diagnosemöglichkeiten1
GTH 2022: Sustainable Collaboration1
Direct Oral Anticoagulants for Pulmonary Embolism1
Nachlese zur Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig1
Acid Treatment of FVIII-Containing Plasma Samples Unmasks a Broad Spectrum of FVIII-Specific Antibodies in ELISA1
1
Subsegmental Pulmonary Embolism1
Veranstaltung des Berufsverbandes im Rahmen des virtuellen GTH-Kongresses 2021, aktuelle Corona-Sonderreglungen und Reimport von Gerinnungsfaktoren1
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 20231
GTH News1
Microvascular Skin Manifestations Caused by COVID-191
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment1
Orale Antikoagulation mit VKA: Nicht-CYP2C9-inhibierende SSRI einsetzen!1
Animal and Cellular Models in Thrombosis and Hemostasis1
1
Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia1
1
A Novel Homozygous Missense Mutation (Ile583Asn) in a Consanguineous Marriage Family with Hereditary Factor XII Deficiency: A Case Report1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives1
Thrombosis and Dissection of the Abdominal Arteries Associated with Infarcts of Solid Organs in a Patient with COVID-19: A Novel Clinical Entity1
iTTP in der Schwangerschaft: Erfolgreiche Behandlung mit Caplacizumab1
Komplementdysregulation als Biomarker für Post Covid1
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future1
Gentherapie in der Hämophilie A und B “Ante Portas”: Aktuelle Entwicklungen in der ärztlichen Vergütung und Bericht Tagung Ethikrat1
An Update on Safe Anticoagulation1
State-of-the-Art Targeted High-Throughput Sequencing for Detecting Inherited Platelet Disorders1
Programm für die Veranstaltung des BDDH im Rahmen der 68. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Wien 2024 und Petition an den Deutschen Bundestag aufgrund eines drohen1
Tranexamsäure hemmt Fibrinolyse nach Kaiserschnitt1
Bleeding Issues in Women Under Oral Anticoagulation1
Reference Intervals in Coagulation Analysis1
GTH News1
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease1
The Diagnostic Assessment of Platelet Function Defects1
Erratum: A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group1
Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline1
GTH News1
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence1
Erhöhte Faktor-VIII-Aktivität – gesteigertes Risiko für Pfortaderthrombosen0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group0
Machine-Learning Applications in Thrombosis and Hemostasis0
The Concept of Thromboinflammation0
Procoagulant Platelets: Mechanisms of Generation and Action0
Effects and Side Effects of Platelet Transfusion0
0
Thrombosis in Acute Promyelocytic Leukemia: The Current Understanding0
Be Curious. Try New Things0
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells0
Update des Versorgungsvertrages nach § 132 i SGBV0
Oral Anticoagulation and Mortality in Cases with Intracranial Bleeding: Analysis of Nationwide Prescription and Hospitalization Data0
The Use of Large Animal Models in Trauma and Bleeding Studies0
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management0
Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A0
Women's Health Issues in Thrombosis and Haemostasis0
Vakzin-induzierte Immunthrombozytopenie und Thrombose: Langfristiger Outcome0
Reshaping Anticoagulation: Factor XI Inhibition in Thrombosis Management0
Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma0
Communication in Healthcare: Global challenges in the 21st Century0
Anticoagulation in Pediatric Patients0
Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)0
0
Thrombozyten: Blutstillung ohne Gerinnselbildung0
COVID-19 and the Incidence of Acute Myocardial Injury0
Laboratory Testing: Current Aspects0
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer0
0
0
Anticoagulation in Patients with Platelet Disorders0
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review0
Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction0
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis0
Laudatio auf Rüdiger E. Scharf0
0
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro0
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications0
Transgender Medicine and Risk of Venous Thromboembolism0
How the COVID-19 Pandemic Impacts Lives of Life Scientists0
Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren0
Treatment of Inherited Platelet Disorders: Current Status and Future Options0
GTH News0
GTH 2021: The First Online Experience! Useful for Future Meetings?0
Intravital Imaging of Thrombosis Models in Mice0
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease0
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH0
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?0
The Diagnostic Assessment of Inherited Platelet Function Defects0
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies0
GTH News0
Management of Recurrent Venous Thromboembolism in Severe Immune Thrombocytopenia: A Case Report and a Review of the Literature0
0
Current Diagnostic and Therapeutic Approaches in May–Thurner Syndrome in Children, Adolescents, and Young Adults: A Survey among Thrombosis Experts of the German Society of Thrombosis and Haemostasis0
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall0
G-BA entscheidet Festgruppe für (plasmatischen) Blutgerinnungsfaktor VIII0
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion0
THROMKIDplus Patient Registry and Biomaterial Banking for Children with Inherited Platelet Disorders0
Pathophysiology of Trauma-Induced Coagulopathy0
Pathogenic Aspects of Inherited Platelet Disorders0
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline0
GTH 2023: The Patient as a Benchmark0
Pitfalls in Coagulation Testing0
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues0
Schwere nächtliche Hypoxie erhöht Wahrscheinlichkeit einer unprovozierten venösen Thromboembolie0
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert0
Do miRNAs Have a Role in Platelet Function Regulation?0
0
Challenging Situations in the Treatment of Cancer-Associated Thrombosis0
GTH News0
Classic Light Transmission Platelet Aggregometry: Do We Still Need it?0
0
Measuring Fibrinolysis0
Aktueller Stand zur Reform der Gebührenordnung für Ärzte (GOÄ)0
Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis0
GTH 2021: ACROSS BORDERS0
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories0
Von Willebrand Disease—Specific Aspects in Women0
Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities0
Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients0
Inflammation, Sepsis, and the Coagulation System0
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype0
0
Leichte Schlaganfälle: Thrombolyse und routinemäßige medi-zinische Versorgung im Vergleich0
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group0
Clonal Hematopoiesis and Cardiovascular Risk: Atherosclerosis, Thrombosis, and beyond0
Clinical Characterization and Molecular Analysis of Fourteen Chinese Patients with Factor V Deficiency0
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)0
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis0
Bleeding Risk in Patients with Cancer0
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia0
Erhöhte Thrombozytenaktivierung bei zirrhotischen Patienten mit Pfortaderthrombose0
DOAC-Dipstick: Algorithmus zum raschen Ausschluss klinisch relevanter Plasmaspiegel von direkten oralen Antikoagulanzien0
Novel Perspectives on Thrombopoietin Receptor Agonists Applications0
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation0
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis0
Acquired von Willebrand Syndrome in Children0
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS10
0
Management of Vascular Thrombosis in Patients with Thrombocytopenia0
Investigations on the Hemostatic Potential of Physiological Body Fluids0
Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)0
Postthrombotisches Syndrom: SOX-PTS-Score und Méan-Modell zeigen beste Prädiktion0
Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline0
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?0
0
Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors0
0.070443868637085